Tyrosine O-sulfation proteoforms affect HIV-1 monoclonal antibody potency

CAP256V2LS, a broadly neutralizing monoclonal antibody (bNAb), is being pursued as a promising drug for HIV-1 prevention. The total level of tyrosine-O-sulfation, a post-translational modification, was known to play a key role for antibody biological activity. More importantly, here wedescribe for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Cindy X., Doria-Rose, Nicole A., Schneck, Nicole A., Ivleva, Vera B., Tippett, Brad, Shadrick, William R., O’Connell, Sarah, Cooper, Jonathan W., Schneiderman, Zachary, Zhang, Baoshan, Gowetski, Daniel B., Blackstock, Daniel, Demirji, Jacob, Lin, Bob C., Gorman, Jason, Liu, Tracy, Li, Yile, McDermott, Adrian B., Kwong, Peter D., Carlton, Kevin, Gall, Jason G., Lei, Q. Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120178/
https://www.ncbi.nlm.nih.gov/pubmed/35589938
http://dx.doi.org/10.1038/s41598-022-12423-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120178/
https://www.ncbi.nlm.nih.gov/pubmed/35589938
http://dx.doi.org/10.1038/s41598-022-12423-x

Ejemplares similares